SMADs: Mediators and regulators of TGF-β signaling

Current Opinion in Genetics and Development

Volumn 8, Issue 1, 1998, Pages 103-111

  Kretzschmar, Marcus ^a   Massagué, Joan ^a  

^a 1275 York Avenue   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; GROWTH FACTOR; MEMBRANE RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; ONCOPROTEIN; PHOSPHOPROTEIN; RAS PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

CANCER; CELL NUCLEUS; COMPLEX FORMATION; ONCOGENE; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; TRANSCRIPTION REGULATION;

EID: 0031911356     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-437X(98)80069-5     Document Type: Article

References (52)

1. Roberts AB, Sporn MB. Sporn MB, Roberts AB. Peptide Growth Factors and Their Receptors. 1990;419-472 Springer-Verlag, Heidelberg.
2. Hogan BLM. Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev. 10:1996;1580-1594.
3. Massagué J, Weis-Garcia F. Pawson T, Parker P. Cancer Surveys Cell signalling. 1996;41-64 ICRF Press, London.
4. Massagué J. TGFβ signaling: receptors, transducers and Mad proteins. Cell. 85:1996;947-950.
5. Raftery LA, Twombly V, Wharton K, Gelbart WM. Genetic screens to identify elements of the decapentaplegic signaling pathway in Drosophila. Genetics. 139:1995;241-254.
6. Sekelsky JJ, Newfeld SJ, Raftery LA, Chartoff EH, Gelbart WM. Genetic characterization and cloning of Mothers against dpp, a gene required for decapentaplegic function in Drosophila melanogaster. Genetics. 139:1995;1347-1358.
7. Watanabe TK, Suzuki M, Omori Y, Hishigaki H, Horie M, Kanemoto N, Fujiwara T, Nakamura Y, Takahashi E. Cloning and characterization of a novel member of the human Mad gene family (MADH6). Genomics. 42:1997;446-451.
8. Yingling JM, Das P, Savage C, Zhang C, Padgett RW, Wang X-F. Mammalian Dwarfins are phosphorylated in response to TGF-β and are implicated in control of cell growth. Proc Natl Acad Sci USA. 93:1996;8940-8944.
9. Liu F, Hata A, Baker J, Doody J, Cárcamo J, Harland R, Massagué J. A human Mad protein acting as a BMP-regulated transcriptional activator. Nature. 381:1996;620-623.
10. Lechleider RJ, de Caestecker MP, Dehejia A, Polymeropoulos MH, Roberts AB. Serine phosphorylation, chromosomal localization and TGFβ signal transduction by human bsp-1. J Biol Chem. 271:1996;17617-17620.
11. Kretzschmar M, Liu F, Hata A, Doody J, Massagué J. The TGF-β family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase. of special interest Genes Dev. 11:1997;984-995 This study identifies conserved carboxy-terminal SSXS motifs as the targets of agonist-induced phosphorylation of pathway-specific SMADs. Evidence is provided that BMP-induced phosphorylation of Smad1 is catalyzed directly by the BMP type I receptor kinase and that it is essential for induced association with Smad4, nuclear accumulation, and transcriptional activity of Smad1.
12. Hoodless PA, Haerry T, Abdollah S, Stapleton M, O'Connor MB, Attisano L, Wrana JL. MADR1, a MAD-related protein that functions in BMP2 signalling pathways. Cell. 85:1996;489-500.
13. Graff JM, Bansal A, Melton DA. Xenopus Mad proteins transduce distinct subsets of signals for the TGFβ superfamily. Cell. 85:1996;479-487.
14. Newfeld SJ, Chartoff EH, Graff JM, Melton DM, Gelbart WM. Mothers against dpp encodes a conserved cytoplasmic protein required in DPP/TGFβ responsive cells. Development. 122:1996;2099-2108.
15. Wiersdorff V, Lecuit T, Cohen SM, Mlodzik M. Mad acts downstream of Dpp receptors, revealing differential requirement for dpp signaling in initiation and propagation of morphogenesis in the Drosophila eye. Development. 122:1996;2153-2162.
16. Savage C, Das P, Finelli A, Townsend SR, Sun C-Y, Baird SE, Padgett RW. Caenorhabditis elegans genes sma-2, sma-3 and sma-4 define a conserved family of transforming growth factor β pathway components. Proc Natl Acad Sci USA. 93:1996;790-794.
17. Zhang Y, Feng X-H, Wu R-Y, Derynck R. Receptor-associated Mad homologues synergize as effectors of the TGFβ response. of outstanding interest Nature. 383:1996;168-172 This study reports the identification of Smad3 as a mediator of TGF-β signaling and demonstrates that different SMADs (i.e. Smad3 and Smad4) synergize to achieve high levels of TGF-β signaling. It also includes data suggesting that Smad3 may associate with and be phosphorylated by the TGF-β receptor complex.
18. Macias-Silva M, Abdollah S, Hoodless PA, Pirone R, Attisano L, Wrana JL. MADR2 is a substrate of the TGFβ receptor and phosphorylation is required for nuclear accumulation and signaling. of outstanding interest Cell. 87:1996;1215-1224 This study demonstrates that Smad2 transiently associates with activated TGF-β receptor complexes and that TGF-β-induced phosphorylation occurs at carboxy-terminal serines catalyzed by the receptor complex. Evidence is provided that receptor-mediated phosphorylation is essential for nuclear accumulation and signaling activity of Smad2.
19. Eppert K, Scherer SW, Ozcelik H, Pirone R, Hoodless P, Kim H, Tsui L-C, Bapat B, Gallinger S, et al. MADR2 maps to 18q21 and encodes a TGFβ-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell. 86:1996;543-552.
20. Baker J, Harland RM. A novel mesoderm inducer, mMadr-2, functions in the activin signal transduction pathway. Genes Dev. 10:1996;1880-1889.
21. Nakao A, Rsijer E, Imamura T, Souchelnytskyi S, Stenman G, Heldin C-H, ten Dijke P. Identification of Smad2, a human Mad-related protein in the transforming growth factor-β signaling pathway. J Biol Chem. 272:1997;2896-2900.
22. Chen X, Rubock MJ, Whitman M. A transcriptional partner of MAD proteins in TGF-β signalling. of outstanding interest Nature. 383:1996;691-696 FAST-1, a new winged-helix transcription factor, is identified as a component of the immediate early activin-responsive factor which binds to an activin-response element in the Xenopus Mix.2 promoter. Smad2 is shown to be part of this complex, suggesting a model for direct involvement of SMADs in transcriptional regulation of TGF-β family target genes.
23. Hahn SA, Schutte M, Hoque ATMS, Moskaluk CA, da Costa LT, Rozenblum E, Weinstein CL, Fischer A, Yeo CJ, Hruban RH, Kern SE. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science. 271:1996;350-353.
24. Schutte M, Hruban RH, Hedrik L, Cho KR, Nadasdy GM, Weinstein CL, Bova GS, Isaacs WB, Cairns P, Nawroz H, et al. DPC4 gene in various tumor types. Cancer Res. 56:1996;2527-2530.
25. Nagatake M, Takagi Y, Osada H, Uchida K, Mitsudomi T, Saji S, Shimokata K, Takahashi T, Takahashi T. Somatic in vivo alterations of the DPC4 gene at 18q21 in human lung cancers. Cancer Res. 56:1996;2718-2720.
26. Kim SK, Fan Y, Papadimitrakopoulou V, Clayman G, Hittelman WN, Hong WK, Lotan R, Mao L. DPC4, a candidate tumor suppressor gene, is altered infrequently in head and neck squamous cell carcinoma. Cancer Res. 56:1996;2519-2521.
27. Barrett MT, Schutte M, Kern SE, Reid BJ. Allelic loss and mutational analysis of the DPC4 gene in esophageal adenocarcinoma. Cancer Res. 56:1996;4351-4353.
28. Lagna G, Hata A, Hemmati-Brivanlou A, Massagué J. Partnership between DPC4 and SMAD proteins in TGFβ signalling pathways. of outstanding interest Nature. 383:1996;832-836 Using both cellular and developmental assays, this study identifies Smad4/DPC4 as a shared intermediate of various TGF-β family signaling pathways. It is demonstrated that Smad4/DPC4, as a common signaling molecule, associates with different pathway-specific SMADs (e.g. Smad1 or Smad2) in response to the respective agonists.
29. Hata A, Lo RS, Wotton D, Lagna G, Massagué J. Mutations increasing auto-inhibition inactivate the tumour suppressors Smad2 and Smad4. of special interest Nature. 388:1997;82-87 The inhibitory function of the amino-terminal domains of Smad2 and Smad4 is shown to involve a direct association with the respective carboxy-terminal domains. Analysis of tumor-derived mutations demonstrates an unusual mechanism of protein inactivation in which the mutations lead to an increase in affinity between the MH1 and MH2 domains and thereby to enhanced autoinhibition.
30. Liu F, Pouponnot C, Massagué J. Dual role of the Smad4/DPC4 tumor suppressor in TGFβ-inducible transcriptional complexes. of special interest Genes Dev. 11:1997;3157-3167 This study demonstrates that Smad4 is not required for nuclear translocation of receptor-activated SMADs but is essential for transcriptional activation as part of a ternary complex with Smad2 and FAST-1 by contributing both DNA-binding and transactivation functions.
31. Massagué J, Hata A, Liu F. TGF-β signalling through the Smad pathway. Tr Cell Biol. 7:1997;187-192.
32. Wu R-Y, Zhang Y, Feng X-H, Derynck R. Heteromeric and homomeric interactions correlate with signaling activity and functional cooperativity of Smad3 and Smad4/DPC4. Mol Cell Biol. 17:1997;2521-2528.
33. Chen X, Weisberg E, Fridmacher V, Watanabe M, Naco G, Whitman M. Smad4 and FAST-1 in the assembly of activin-responsive factor. of special interest Nature. 389:1997;85-89 This study sheds light on the role of Smad4 in activin signaling by demonstrating that Smad4 is a component of the activin-response factor together with Smad2 and FAST-1. The work suggests that Smad4 might be needed to stabilize the activin-induced Smad2-FAST-1 complex as an active DNA-binding entity.
34. Shi Y, Hata A, Lo RS, Massagué J, Pavletich NP. Insights into Smad family function from a crystallographic analysis of the Smad4/DPC4 tumor suppressor C-terminal domain. of outstanding interest Nature. 388:1997;87-93 The first crystallographic study of a SMAD protein shows the carboxy-terminal effector domain of Smad4 as a trimeric complex, in which the protein-protein interface is formed by conserved residues. Most of the tumor-derived missense mutations in Smad4 map to this interface suggesting that disruption of the trimeric assembly may lead to inactivation of TGF-β signaling.
35. Kim J, Johnson K, Chen HJ, Carroll S, Laughon A. Drosophila Mad binds to DNA and directly mediates activation of vestigial by Decapentaplegic. of special interest Nature. 388:1997;304-308 This study shows that the amino-terminal domain of Mad has DNA-binding activity and that it recognizes an enhancer sequence which requires Mad function for Dpp-induced activation. DNA-binding activity is repressed by the presence of the carboxy-terminal domain, suggesting that Dpp signals regulate target gene expression by stimulating DNA-binding activity of Mad.
36. Huang H-C, Murtaugh LC, Vize PD, Whitman M. Identification of a potential regulator of early transcriptional responses to mesoderm inducers in the frog embryo. EMBO J. 14:1995;5965-5973.
37. Wang T, Li B-Y, Danielson PD, Shah PC, Rockwell S, Lechleider RJ, Martin J, Mangnaro T, Donahoe PK. The immunophilin FKBP12 functions as a common inhibitor of the TGFβ family type I receptors. Cell. 86:1996;435-444.
38. Chen Y-G, Liu F, Massagué J. Mechanism of TGFβ receptor inhibition by FKBP12. EMBO J. 16:1997;3866-3876.
39. Chen R-H, Miettinen PJ, Maruoka EM, Choy L, Derynck R. A WD-domain protein that is associated with and phosphorylated by the type II TGF-β receptor. Nature. 377:1995;548-552.
40. Topper JN, Cai J, Qiu Y, Anderson KR, Xu Y-Y, Deeds JD, Feeley R, Gimeno CJ, Woolf EA, Tayber O, et al. Vascular MADs: two novel MAD-related genes selectively inducible by flow in human vascular endothelium. Proc Natl Acad Sci USA. 94:1997;9314-9319.
41. Nakao A, Afrakhte M, Morén A, Nakayama T, Christian JL, Heuchel R, Itoh S, Kawabata M, Heldin N-E, Heldin C-H, ten Dijke P. Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signaling. of outstanding interest Nature. 389:1997;631-636 This paper and the three following papers [42-44] demonstrate that Smad6, Smad7 and Dad are inhibitors of TGF-β or BMP receptor signaling. Smad6 and Smad7 can interact with the activated TGF-β and BMP receptors and this is proposed to inhibit signaling by these receptors. Thus, a novel way of regulating TGF-β-signaling intracellularly is defined.
42. Hayashi H, Abdollah S, Qiu Y, Cai J, Xu Y-Y, Grinnell BW, Richardson MA, Topper JN, Gimbrone MA, Wrana JL, Falb D. The MAD-related protein Smad7 associates with the TGFβ receptor and functions as an antagonist of the TGFβ signaling. of outstanding interest Cell. 89:1997;1165-1173 See annotation [41].
43. Imamura T, Takase M, Nishihara A, Oeda E, Hanai J, Kawabata M, Miyazono K. Smad6 inhibits signalling by the TGF-β superfamily. of outstanding interest Nature. 389:1997;622-626 See annotation [41].
44. Tsuneizumi K, Nakayama T, Kamoshida Y, Kornberg TB, Christian JL, Tabata T. Daughters against dpp modulates dpp organizing activity in Drosophila wing development. of outstanding interest Nature. 389:1997;627-631 See annotation [41].
45. Kretzschmar M, Doody J, Massagué J. Opposing BMP and EGF signalling pathways converge on the TGF-β family mediator Smad1. of outstanding interest Nature. 389:1997;618-622 This work identifies a novel mechanism of regulation of Smad1-mediated BMP signaling. It is shown that phosphorylation in the central region of Smad1, catalyzed by Erk MAP-kinases, inhibits nuclear accumulation of Smad1. By this means, receptor tyrosine kinase activating growth factors, such as EGF, can antagonize BMP-induced nuclear activity of Smad1.
46. Niswander L, Martin GR. FGF-4 and BMP-2 have opposite effects on limb growth. Nature. 361:1993;68-71.
47. Ganan Y, Macias D, Duterque-Coquillaud M, Ros MA, Hurle JM. Role of TGFβs and BMPs as signals controlling the position of the digits and the areas of interdigital cell death in the developing chick limb autopod. Development. 122:1996;2349-2357.
48. Bernier SM, Goltzman D. Effect of protein and steroidal osteotropic agents on differentiation and epidermal growth factor-mediated growth of the CFK1 osseous cell line. J Cell Physiol. 152:1992;317-327.
49. Neubüser A, Peters H, Balling R, Martin GR. Antagonistic interactions between FGF and BMP signaling pathways: a mechanism for positioning the sites of tooth formation. Cell. 90:1997;247-255.
50. Uchida K, Nagatake M, Osada H, Yatabe Y, Kondo M, Mitsudomi T, Masuda A, Takahashi T, Takahashi T. Somatic in vivo alterations of the JV18-1 gene at 18q21 in human lung cancers. Cancer Res. 56:1996;5583-5585.
51. Riggins GJ, Thiagalingam S, Rozenblum E, Weinstein CL, Kern SE, Hamilton SR, Willson JKV, Markowitz SD, Kinzler KW, Vogelstein B. Mad-related genes in the human. Nat Genet. 13:1996;347-349.
52. Hata A, Lagna G, Massagué J, Hemmati-Brivanlou A. Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumour suppressor. of outstanding interest Genes Dev. 12:1998;186-197 See annotation [41].